Published in J Clin Microbiol on October 01, 1995
Detection and identification of mycobacteria by DNA amplification and oligonucleotide-specific capture plate hybridization. J Clin Microbiol (1995) 1.94
Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol (1998) 1.85
Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey. J Clin Microbiol (1996) 1.38
Identification and subspecific differentiation of Mycobacterium scrofulaceum by automated sequencing of a region of the gene (hsp65) encoding a 65-kilodalton heat shock protein. J Clin Microbiol (1996) 1.23
Cervical lymphadenitis due to an unusual mycobacterium. Eur J Clin Microbiol Infect Dis (1997) 1.14
Gamma interferon is essential for clearing Mycobacterium genavense infection. Infect Immun (2000) 0.91
Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature. Eur J Epidemiol (1998) 0.89
Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction. Eur J Clin Microbiol Infect Dis (1997) 0.84
Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res (1989) 19.85
Detection and identification of mycobacteria by amplification of rRNA. J Clin Microbiol (1990) 12.41
A method for counting acid-fast bacteria. Int J Lepr Other Mycobact Dis (1968) 8.01
Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium. Int J Syst Bacteriol (1990) 7.65
Differentiation of Mycobacterium species by direct sequencing of amplified DNA. J Gen Microbiol (1990) 7.33
Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet (1992) 4.42
Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite. N Engl J Med (1993) 3.75
Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species. Int J Syst Bacteriol (1992) 3.65
Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome. N Engl J Med (1990) 2.54
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. Ann Intern Med (1990) 2.45
Organization of rRNA genes in Mycobacterium bovis BCG. J Bacteriol (1987) 2.33
[Taxonomic value of mycobacterial fatty acids: proposal for a method of analysis]. Ann Microbiol (Paris) (1984) 2.27
Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis (1968) 2.03
Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Arch Intern Med (1995) 1.95
In vitro and in vivo activities of macrolides against Mycobacterium leprae. Antimicrob Agents Chemother (1988) 1.89
Mycobacterium genavense sp. nov. Int J Syst Bacteriol (1993) 1.88
Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J Clin Microbiol (1992) 1.82
Selective isolation of mycobacteria from soil: a statistical analysis approach. J Gen Microbiol (1988) 1.62
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. J Infect Dis (1987) 1.60
Isolation of mycobacteria from healthy persons' stools. Int J Lepr Other Mycobact Dis (1988) 1.55
Mycobacteriosis due to Mycobacterium genavense in six pet birds. J Clin Microbiol (1993) 1.49
Fatty and mycolic acids of Mycobacterium malmoense. J Clin Microbiol (1988) 1.40
Binding of 14C-labeled dopa by Mycobacterium leprae in vitro. Int J Lepr Other Mycobact Dis (1976) 1.22
Isolation of a fastidious Mycobacterium species from two AIDS patients. J Clin Microbiol (1992) 1.21
Rapid methods for counting mycobacteria--comparison of methods for extraction of mycobacterial adenosine triphosphate (ATP) determined by firefly luciferase assay. Tubercle (1985) 1.21
Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS (1993) 1.19
Invasive infection with Mycobacterium genavense in three children with the acquired immunodeficiency syndrome. Eur J Clin Microbiol Infect Dis (1993) 1.13
A cooperative taxonomic study of mycobacteria isolated from armadillos infected with Mycobacterium leprae. J Gen Microbiol (1986) 1.09
Adenosine triphosphate content of Mycobacterium leprae isolated from armadillo tissue by Percoll buoyant density centrifugation. Int J Lepr Other Mycobact Dis (1986) 1.07
Biochemical properties and fatty acid composition of Mycobacterium haemophilum: study of 16 isolates from Australian patients. J Clin Microbiol (1993) 1.02
Mycobacterium genavense. Autopsy findings in three patients. Am J Clin Pathol (1994) 1.01
[AIDS and atypical mycobacteria]. Ann Soc Belg Med Trop (1987) 0.90
Disseminated Mycobacterium genavense infection in two patients with AIDS. Clin Infect Dis (1994) 0.88
Ultrastructural characterization of normal and damaged membranes of Mycobacterium leprae and of cultivable mycobacteria. J Gen Microbiol (1984) 0.88
[Disseminated nontuberculous mycobacterial infections in AIDS patients]. Schweiz Med Wochenschr (1994) 0.87
[Mycobacterium genavense infection in AIDS]. Dtsch Med Wochenschr (1993) 0.83
Parameters influencing the in vitro growth of Mycobacterium lepraemurium. Int J Lepr Other Mycobact Dis (1981) 0.83
New data on the ultrastructure of the membrane of Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1989) 0.77
Bacteriological studies of armadillo livers infected with Mycobacterium leprae. Ann Soc Belg Med Trop (1982) 0.76
Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res (1989) 19.85
Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol (1993) 18.91
Detection and identification of mycobacteria by amplification of rRNA. J Clin Microbiol (1990) 12.41
Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol (1993) 9.76
Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium. Int J Syst Bacteriol (1990) 7.65
Differentiation of Mycobacterium species by direct sequencing of amplified DNA. J Gen Microbiol (1990) 7.33
Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol (1996) 5.80
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83
Insects in the transmission of Mycobacterium ulcerans infection. Lancet (1999) 4.46
Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet (1992) 4.42
Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet (1996) 4.22
Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol (1993) 3.83
Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite. N Engl J Med (1993) 3.75
Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother (1997) 3.55
Identification of Mycobacterium species by using amplified ribosomal DNA restriction analysis. J Clin Microbiol (1993) 3.38
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother (1994) 3.28
Residential culturable fungi, (1-3, 1-6)-β-d-glucan, and ergosterol concentrations in dust are not associated with asthma, rhinitis, or eczema diagnoses in children. Indoor Air (2013) 3.27
16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol (2006) 3.25
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med (1998) 3.24
Elimination of contaminating DNA within polymerase chain reaction reagents: implications for a general approach to detection of uncultured pathogens. J Clin Microbiol (1993) 3.22
Microheterogeneity within rRNA of Mycobacterium gordonae. J Clin Microbiol (1992) 3.20
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1999) 3.16
Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J Clin Microbiol (2009) 3.08
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science (1989) 2.93
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother (1996) 2.92
Mycobacterium ulcerans in wild animals. Rev Sci Tech (2001) 2.84
Fatal strongyloidiasis in immunosuppressed patients. Am J Med (1974) 2.76
Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis (1987) 2.71
Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol Respir Environ Exerc Physiol (1979) 2.68
Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol (1996) 2.66
Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome. N Engl J Med (1990) 2.54
Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol (1995) 2.50
Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J Clin Microbiol (1997) 2.50
rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol (1995) 2.49
Phylogenetic analysis and identification of different serovars of Mycobacterium intracellulare at the molecular level. FEMS Microbiol Lett (1990) 2.47
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (2001) 2.42
Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol (2001) 2.38
A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis (1998) 2.34
16S rRNA sequence diversity in Mycobacterium celatum strains caused by presence of two different copies of 16S rRNA gene. J Clin Microbiol (1998) 2.33
Genetic heterogeneity within Mycobacterium fortuitum complex species: genotypic criteria for identification. J Clin Microbiol (1992) 2.30
Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout. Int J Tuberc Lung Dis (2012) 2.27
Evaluation of polymerase chain reaction, tuberculostearic acid analysis, and direct microscopy for the detection of Mycobacterium tuberculosis in sputum. J Infect Dis (1992) 2.24
Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol (1997) 2.24
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study. Clin Infect Dis (2001) 2.24
Frequent contamination of Taq polymerase with DNA. Clin Chem (1990) 2.23
Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob Agents Chemother (1994) 2.23
Identification of mycobacteria by PCR-based sequence determination of the 32-kilodalton protein gene. J Clin Microbiol (1994) 2.20
Species identification of mycobacteria using rDNA sequencing. Methods Mol Biol (1998) 2.19
Two different 16S rRNA genes in a mycobacterial strain. J Clin Microbiol (1996) 2.17
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study. N Engl J Med (1999) 2.17
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science (1988) 2.17
A cohort study of drug users' compliance with zidovudine treatment. Arch Intern Med (1994) 2.16
Cloning and analysis of the K1 capsule biosynthesis genes of Escherichia coli: lack of homology with Neisseria meningitidis group B DNA sequences. Infect Immun (1983) 2.15
Evidence-based strategies for preventing drug administration errors during anaesthesia. Anaesthesia (2004) 2.15
Characterization and distribution of Pasteurella species recovered from infected humans. J Clin Microbiol (1992) 2.12
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med (2008) 2.03
Ribosomal DNA sequencing for identification of aerobic gram-positive rods in the clinical laboratory (an 18-month evaluation). J Clin Microbiol (2003) 2.02
[HIV epidemic: an end to exceptional regulation? Response to the article which appeared under this title in the Revue médicale de la Suisse romande (112, 239-241, 1991)]. Rev Med Suisse Romande (1992) 2.02
Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study. Ann Intern Med (1991) 2.02
Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1996) 2.02
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01
Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries. Int J Tuberc Lung Dis (2005) 2.01
Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J Virol (2007) 1.98
Comparison of conventional and molecular methods for identification of aerobic catalase-negative gram-positive cocci in the clinical laboratory. J Clin Microbiol (2004) 1.96
Diagnosis of mycobacterial infections by nucleic acid amplification: 18-month prospective study. J Clin Microbiol (1996) 1.94
Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat Med (1998) 1.94
Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg (1974) 1.89
Mycobacterium genavense sp. nov. Int J Syst Bacteriol (1993) 1.88
Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int (2001) 1.88
Rapid identification of Mycobacteria to the species level using INNO-LiPA Mycobacteria, a reverse hybridization assay. J Clin Microbiol (2001) 1.85
Airborne bacteria, endotoxin and fungi in dust in poultry and swine confinement buildings. Am Ind Hyg Assoc J (1983) 1.83
Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J Clin Microbiol (1992) 1.82
Detection of human immunodeficiency virus type 1 (HIV-1) in heel prick blood on filter paper from children born to HIV-1-seropositive mothers. J Clin Microbiol (1994) 1.81
In vitro susceptibility of Mycobacterium ulcerans to clarithromycin. Antimicrob Agents Chemother (1998) 1.80
Burden of unidentifiable mycobacteria in a reference laboratory. J Clin Microbiol (2001) 1.79
Mycobacterium lentiflavum: an etiologic agent of cervical lymphadenitis. Clin Infect Dis (1997) 1.79
Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22--65 years. Acta Physiol Scand (1978) 1.76
Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis (2001) 1.75
Mycobacterium intermedium sp. nov. Int J Syst Bacteriol (1993) 1.75
Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene function. Cell (1987) 1.74
Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis. J Clin Microbiol (1993) 1.73
Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis (1998) 1.72
Mycobacterium branderi sp. nov., a new potential human pathogen. Int J Syst Bacteriol (1995) 1.71
Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother (2005) 1.70
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70
Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1999) 1.69
Characterization of an unusual Mycobacterium: a possible missing link between Mycobacterium marinum and Mycobacterium ulcerans. J Clin Microbiol (2002) 1.67
Is second-line anti-tuberculosis drug susceptibility testing reliable? Int J Tuberc Lung Dis (2004) 1.67
Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol (2004) 1.67
Red fingers syndrome in patients with HIV and hepatitis C infection. Lancet (1996) 1.66
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J Virol (1998) 1.65